MIST:NASDAQ, Milestone Pharmaceuticals Inc.

Why MIST stock fell on November 16

Milestone Pharmaceuticals Inc. fell 29.8% on Monday, November 16, 2026, on 8,721,818 shares, 5.9 times its average daily volume. No headline about MIST came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

MIST stock overview

Milestone Pharmaceuticals Inc. (MIST:NASDAQ) closed at $0.422 on November 17, 2026, up 15.59% on the day. The stock trades 86.2% below its 52-week high of $3.06 and 16.5% above its 52-week low of $0.362. Over the past year, it lost 84.3%. Milestone Pharmaceuticals Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$0.422
Day change
+15.59%
Volume
4,090,285
Average volume
1,486,557
Market cap
52M+
52-week range
$0.362 – $3.06
50-day average
$0.785
200-day average
$1.30

Price action over the past year

In 252 trading sessions since November 14, 2025, MIST closed higher on 102 days (40%). Its best day was March 31, 2026 (+17.82%) and its worst was November 16, 2026 (-29.81%). The stock moved 10% or more in a single session 18 times.

Recent signals

MIST news

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.

Similar stocks

Find more stocks like MIST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.